ETF comparison
IXJvsXLV
Both Healthcare.
iShares Global Healthcare ETF · State Street Health Care Select Sector SPDR ETF
Holdings overlap
60 positions appear in both funds. Buying equal dollars of IXJ and XLV would leave roughly70.9%of each dollar exposed to the same underlying securities.
Side by side
Sub-score comparison
Tracking quality isn't part of the composite — seewhat we don't scorefor why.
Cost difference
XLV is 30 bps cheaper than IXJ. On a $100,000 position that's about $300/yr more in fees for IXJ.
Fee figure is the annual expense charged on $100,000. To see how the gap compounds over a multi-decade holding period, open thecost calculator pre-filled with IXJ vs XLV.
Top shared holdings
60 shared in total| # | Holding | In IXJ | In XLV | Overlap |
|---|---|---|---|---|
| 1 | ELI LILLY AND COMPANY | 10.93% | 16.51% | 10.93% |
| 2 | JOHNSON & JOHNSON | 7.04% | 10.64% | 7.04% |
| 3 | ABBVIE INC. | 5.12% | 7.74% | 5.12% |
| 4 | UNITEDHEALTH GROUP INCORPORATED | 4.40% | 6.57% | 4.40% |
| 5 | MERCK & CO., INC. | 4.12% | 5.52% | 4.12% |
| 6 | AMGEN INC. | 2.54% | 3.40% | 2.54% |
| 7 | THERMO FISHER SCIENTIFIC INCORPORATED | 2.42% | 3.24% | 2.42% |
| 8 | ABBOTT LABORATORIES | 2.05% | 2.75% | 2.05% |
| 9 | GILEAD SCIENCES, INC. | 2.04% | 2.73% | 2.04% |
| 10 | INTUITIVE SURGICAL, INC. | 1.83% | 2.45% | 1.83% |
| 11 | PFIZER INC. | 1.78% | 2.39% | 1.78% |
| 12 | CVS HEALTH CORPORATION | 1.71% | 2.30% | 1.71% |
Only in IXJ
50 total- ASTRAZENECA PLC3.76%
- Roche Holding AG3.75%
- Novartis AG3.71%
- NOVO NORDISK A/S1.99%
- GSK PLC1.38%
- SANOFI SA1.18%
- argenx SE0.74%
- ESSILORLUXOTTICA SA0.71%
- Bayer Aktiengesellschaft0.71%
- HOYA CORPORATION0.70%
Only in XLV
1 total- State Street Global Advisors0.01%
Open IXJ or XLV at a brokerage
Both funds trade commission-free at major US brokerages.
Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodologyand funding disclosure.
Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see/methodology/.
Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.